- Home
- SMHI vs THRD Comparison
SMHI vs THRD Comparison
Compare SMHI & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMHI
- THRD
- Stock Information
- Founded
- SMHI 1989
- THRD 2019
- Country
- SMHI United States
- THRD United States
- Employees
- SMHI N/A
- THRD 53
- Industry
- SMHI Marine Transportation
- THRD Biotechnology: Pharmaceutical Preparations
- Sector
- SMHI Consumer Discretionary
- THRD Health Care
- Exchange
- SMHI Nasdaq
- THRD Nasdaq
- Market Cap
- SMHI 142.2M
- THRD 164.2M
- IPO Year
- SMHI N/A
- THRD 2022
- Fundamental
- Price
- SMHI $4.61
- THRD $5.16
- Analyst Decision
- SMHI
- THRD Hold
- Analyst Count
- SMHI 0
- THRD 3
- Target Price
- SMHI N/A
- THRD $5.00
- AVG Volume (30 Days)
- SMHI 141.9K
- THRD 1.1M
- Earning Date
- SMHI 04-30-2025
- THRD 05-14-2025
- Dividend Yield
- SMHI N/A
- THRD N/A
- EPS Growth
- SMHI N/A
- THRD N/A
- EPS
- SMHI N/A
- THRD N/A
- Revenue
- SMHI $271,361,000.00
- THRD N/A
- Revenue This Year
- SMHI $8.07
- THRD N/A
- Revenue Next Year
- SMHI $7.29
- THRD N/A
- P/E Ratio
- SMHI N/A
- THRD N/A
- Revenue Growth
- SMHI N/A
- THRD N/A
- 52 Week Low
- SMHI $3.63
- THRD $3.18
- 52 Week High
- SMHI $15.36
- THRD $16.94
- Technical
- Relative Strength Index (RSI)
- SMHI 46.15
- THRD 80.42
- Support Level
- SMHI $4.02
- THRD $3.30
- Resistance Level
- SMHI $4.59
- THRD $5.15
- Average True Range (ATR)
- SMHI 0.50
- THRD 0.16
- MACD
- SMHI 0.01
- THRD 0.24
- Stochastic Oscillator
- SMHI 63.23
- THRD 99.47
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.